Health Affairs, 26, no. 3 (2007): 647-652 doi: 10.1377/hlthaff.26.3.647 © 2007 by Project HOPE	New Online   How Would Obama, McCain Cover The Uninsured?   Debating Cost Of Uninsured   Try Medicare-For-All   HA Blog Top 10

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Juhn, P. Articles by Buto, K. Search for Related Content PubMed Articles by Juhn, P. Articles by Buto, K. Related Collections Consumer Issues Pharmaceuticals Research And Technology

Perspective

PERSPECTIVE

Balancing Modern Medical Benefits And Risks

The changing landscape of medical benefits and risks creates new challenges for all stakeholders in health care. We offer examples of different medical interventions to help illustrate the complexity and diversity of considerations that define the trade-offs between benefits and risks for each patient. As more information becomes available at all stages of a product’s life cycle, the Food and Drug Administration (FDA) needs to play a central role as an authoritative voice in communicating drugs’ benefits and risks and must have the resources to perform the functions necessary to keep pace with this accelerating rate of change.

                      What's this?

eLetters: